IBDEI1MJ ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,25948,1,4,0)
 ;;=4^R30.0
 ;;^UTILITY(U,$J,358.3,25948,2)
 ;;=^5019322
 ;;^UTILITY(U,$J,358.3,25949,0)
 ;;=N92.1^^107^1227^39
 ;;^UTILITY(U,$J,358.3,25949,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25949,1,3,0)
 ;;=3^Excessive/Frequent Menstruation w/ Irregular Cycle
 ;;^UTILITY(U,$J,358.3,25949,1,4,0)
 ;;=4^N92.1
 ;;^UTILITY(U,$J,358.3,25949,2)
 ;;=^5015909
 ;;^UTILITY(U,$J,358.3,25950,0)
 ;;=Z08.^^107^1227^41
 ;;^UTILITY(U,$J,358.3,25950,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25950,1,3,0)
 ;;=3^F/U Exam After Malig Neop Treatment
 ;;^UTILITY(U,$J,358.3,25950,1,4,0)
 ;;=4^Z08.
 ;;^UTILITY(U,$J,358.3,25950,2)
 ;;=^5062667
 ;;^UTILITY(U,$J,358.3,25951,0)
 ;;=Z80.3^^107^1227^42
 ;;^UTILITY(U,$J,358.3,25951,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25951,1,3,0)
 ;;=3^Family Hx of Breast CA
 ;;^UTILITY(U,$J,358.3,25951,1,4,0)
 ;;=4^Z80.3
 ;;^UTILITY(U,$J,358.3,25951,2)
 ;;=^5063347
 ;;^UTILITY(U,$J,358.3,25952,0)
 ;;=Z80.49^^107^1227^43
 ;;^UTILITY(U,$J,358.3,25952,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25952,1,3,0)
 ;;=3^Family Hx of Genital Organ CA
 ;;^UTILITY(U,$J,358.3,25952,1,4,0)
 ;;=4^Z80.49
 ;;^UTILITY(U,$J,358.3,25952,2)
 ;;=^5063351
 ;;^UTILITY(U,$J,358.3,25953,0)
 ;;=Z80.41^^107^1227^44
 ;;^UTILITY(U,$J,358.3,25953,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25953,1,3,0)
 ;;=3^Family Hx of Ovarian CA
 ;;^UTILITY(U,$J,358.3,25953,1,4,0)
 ;;=4^Z80.41
 ;;^UTILITY(U,$J,358.3,25953,2)
 ;;=^5063348
 ;;^UTILITY(U,$J,358.3,25954,0)
 ;;=N73.9^^107^1227^47
 ;;^UTILITY(U,$J,358.3,25954,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25954,1,3,0)
 ;;=3^Female Pelvic Inflammatory Disease,Unspec
 ;;^UTILITY(U,$J,358.3,25954,1,4,0)
 ;;=4^N73.9
 ;;^UTILITY(U,$J,358.3,25954,2)
 ;;=^5015820
 ;;^UTILITY(U,$J,358.3,25955,0)
 ;;=N60.32^^107^1227^48
 ;;^UTILITY(U,$J,358.3,25955,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25955,1,3,0)
 ;;=3^Fibrosclerosis,Left Breast
 ;;^UTILITY(U,$J,358.3,25955,1,4,0)
 ;;=4^N60.32
 ;;^UTILITY(U,$J,358.3,25955,2)
 ;;=^5015780
 ;;^UTILITY(U,$J,358.3,25956,0)
 ;;=N60.31^^107^1227^49
 ;;^UTILITY(U,$J,358.3,25956,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25956,1,3,0)
 ;;=3^Fibrosclerosis,Right Breast
 ;;^UTILITY(U,$J,358.3,25956,1,4,0)
 ;;=4^N60.31
 ;;^UTILITY(U,$J,358.3,25956,2)
 ;;=^5015779
 ;;^UTILITY(U,$J,358.3,25957,0)
 ;;=Z01.411^^107^1227^50
 ;;^UTILITY(U,$J,358.3,25957,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25957,1,3,0)
 ;;=3^GYN Exam w/ Abnormal Findings
 ;;^UTILITY(U,$J,358.3,25957,1,4,0)
 ;;=4^Z01.411
 ;;^UTILITY(U,$J,358.3,25957,2)
 ;;=^5062622
 ;;^UTILITY(U,$J,358.3,25958,0)
 ;;=Z01.419^^107^1227^1
 ;;^UTILITY(U,$J,358.3,25958,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25958,1,3,0)
 ;;=3
 ;;^UTILITY(U,$J,358.3,25958,1,4,0)
 ;;=4^Z01.419
 ;;^UTILITY(U,$J,358.3,25958,2)
 ;;=^5062623
 ;;^UTILITY(U,$J,358.3,25959,0)
 ;;=Z01.419^^107^1227^51
 ;;^UTILITY(U,$J,358.3,25959,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25959,1,3,0)
 ;;=3^GYN Exam w/ Normal Findings
 ;;^UTILITY(U,$J,358.3,25959,1,4,0)
 ;;=4^Z01.419
 ;;^UTILITY(U,$J,358.3,25959,2)
 ;;=^5062623
 ;;^UTILITY(U,$J,358.3,25960,0)
 ;;=R87.613^^107^1227^53
 ;;^UTILITY(U,$J,358.3,25960,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25960,1,3,0)
 ;;=3^HGSIL
 ;;^UTILITY(U,$J,358.3,25960,1,4,0)
 ;;=4^R87.613
 ;;^UTILITY(U,$J,358.3,25960,2)
 ;;=^5019671
 ;;^UTILITY(U,$J,358.3,25961,0)
 ;;=R87.612^^107^1227^63
